Product Code: ETC8848305 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The pediatric vaccines market in the Philippines is critical to public health, covering routine immunizations for diseases such as measles, polio, and hepatitis. Government programs and partnerships with global health bodies ensure wide vaccine coverage. The market continues to grow with the introduction of new combination vaccines and cold chain infrastructure improvements.
The pediatric vaccines market in the Philippines is robust, supported by national immunization programs and strong government commitment to child health. Vaccines for polio, measles, hepatitis, and rotavirus are widely administered, and newer vaccines are being introduced through international collaborations and donor funding.
The pediatric vaccines market is constrained by supply chain inefficiencies, vaccine hesitancy, and gaps in immunization outreach, especially in remote provinces. Although government initiatives have improved access, logistical challenges and cold chain maintenance remain persistent hurdles.
The pediatric vaccines market in the Philippines remains a high-potential sector due to ongoing government immunization programs and increasing private sector participation. Investments in local vaccine production, cold chain logistics, and public-private partnerships can help improve coverage and accessibility. The growing population and recurrent outbreaks of preventable diseases make this a resilient and socially impactful investment domain.
The Philippine government has faced challenges in its vaccination programs due to vaccine hesitancy. In 2019, controversies surrounding the dengue vaccine Dengvaxia led to a decline in public trust and subsequent outbreaks of preventable diseases . Efforts are ongoing to rebuild confidence in immunization programs and ensure the availability of pediatric vaccines nationwide.?
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Pediatric Vaccines Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Pediatric Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Pediatric Vaccines Market - Industry Life Cycle |
3.4 Philippines Pediatric Vaccines Market - Porter's Five Forces |
3.5 Philippines Pediatric Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Pediatric Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Philippines Pediatric Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Philippines Pediatric Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Pediatric Vaccines Market Trends |
6 Philippines Pediatric Vaccines Market, By Types |
6.1 Philippines Pediatric Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Pediatric Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Pediatric Vaccines Market Revenues & Volume, By Monovalent, 2021- 2031F |
6.1.4 Philippines Pediatric Vaccines Market Revenues & Volume, By Multivalent, 2021- 2031F |
6.2 Philippines Pediatric Vaccines Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Philippines Pediatric Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F |
6.2.3 Philippines Pediatric Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.2.4 Philippines Pediatric Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.2.5 Philippines Pediatric Vaccines Market Revenues & Volume, By Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, 2021- 2031F |
6.3 Philippines Pediatric Vaccines Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Philippines Pediatric Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3.3 Philippines Pediatric Vaccines Market Revenues & Volume, By Human Papilloma Virus, 2021- 2031F |
6.3.4 Philippines Pediatric Vaccines Market Revenues & Volume, By Measles, Mumps and Rubella, 2021- 2031F |
6.3.5 Philippines Pediatric Vaccines Market Revenues & Volume, By Meningococcal Disease, 2021- 2031F |
6.3.6 Philippines Pediatric Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.3.7 Philippines Pediatric Vaccines Market Revenues & Volume, By Polio, 2021- 2031F |
6.3.8 Philippines Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
6.3.9 Philippines Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
7 Philippines Pediatric Vaccines Market Import-Export Trade Statistics |
7.1 Philippines Pediatric Vaccines Market Export to Major Countries |
7.2 Philippines Pediatric Vaccines Market Imports from Major Countries |
8 Philippines Pediatric Vaccines Market Key Performance Indicators |
9 Philippines Pediatric Vaccines Market - Opportunity Assessment |
9.1 Philippines Pediatric Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Pediatric Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Philippines Pediatric Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Philippines Pediatric Vaccines Market - Competitive Landscape |
10.1 Philippines Pediatric Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Philippines Pediatric Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |